A Pittsburgh-area man is not just giving people living with ALS a voice, he's giving them their own voice. A recent diagnosis ...

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...

The ALS Network, in partnership with ALS United, today announced that Letters of Intent (LOIs) for ALS research funding will be accepted from March 16 through April 20, 2026, as part of the ...

Columnist Juliet Taylor reflects on the legacy of Leah Stavenhagen, who founded Her ALS Story for young women diagnosed with the disease.

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic ...

For columnist Dagmar Munn, reducing uncertainty in one area of her life with ALS would mean keeping her ALS progression right where it is.

Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is one of the most brutal diseases out there. Per Mayo Clinic, ...

Dana Hunt was diagnosis with ALS from three years ago. But instead of slowing down, she leaned into the life she’s always ...

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases, today ...

The centerpiece of this effort is the premiere of 11 Voices - the first docuseries where people with voice loss narrate their ...